Skip to content

Enhanced recovery after surgery in adenoid tonsillectomy: reduced perioperative pain and length of stay-- a randomized control trial

Enhanced recovery after surgery in adenoid tonsillectomy: reduced perioperative pain and length of stay

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069702
Enrollment
Unknown
Registered
2023-03-23
Start date
2020-09-24
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsil adenoid hypertrophy

Interventions

Control group:Normal surgical procedure

Sponsors

The Fifth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Obtain the consent of the subject's legal guardian, voluntarily participate in this research and abide by the research regulations, agree to the operation, understand and abide by the follow-up plan, and correctly record the scale score, frequency of medication, concomitant medication and adverse event records, etc. The legal guardian voluntarily signs a written informed consent form. If the minor can make a decision of informed consent to participate in the research, he must also voluntarily participate in the research and abide by the research regulations; 2. The age of the subject is 3-14 years old; 3. Gender is not limited, limited to Chinese; 4. Accompanied by varying degrees of snoring and mouth breathing; 5. Meet the indications for tonsil with adenoid hypertrophy surgery; 6. No serious heart, lung, brain disease and metabolic disease; 7. No malnutrition; 8. Normal lung function; 9. No history of tonsil inflammation and upper respiratory tract infection within 3 to 4 weeks; 10. Laboratory test indicators are normal.

Exclusion criteria

Exclusion criteria: 1. Combined with respiratory abnormalities; 2. Morbid or simply obese children; 3. Local anesthetic drug allergy, analgesic drug dependence, local infection injury at the injection site, clinically serious metabolic, cardiovascular, immune, nervous, blood, digestive, cerebrovascular or respiratory system diseases, or any interference with the research in the opinion of the researcher Assessment of outcomes or illnesses affecting subject safety; 4. Currently participating in other clinical research or participating in other clinical research within 30 days, or staff directly involved in this research; 5. Have a history of mental illness, confrontational personality, bad motivation, suspicious or other emotional or intellectual problems, which may affect the informed validity of participating in the research.

Design outcomes

Primary

MeasureTime frame
Pain score;Restlessness score;Hospital stay;Hospitalization expenses;

Secondary

MeasureTime frame
Postoperative complications;Postoperative analgesics;Stress indicators;

Countries

China

Contacts

Public ContactHong Haiyu

The Fifth Affiliated Hospital of Sun Yat-sen University

honghy@mail.sysu.edu.cn+86 138 2307 0089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026